Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Gross) (2011 - 2025)
Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Gross) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Gross) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.43 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 19.22 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 5.11 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 261.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 208.10 Mn |
| Dec 31, 2025 | 208.10 Mn |
| Dec 31, 2024 | 189.10 Mn |
| Dec 31, 2024 | 189.10 Mn |
| Dec 31, 2023 | 153.80 Mn |
| Dec 31, 2023 | 153.80 Mn |
| Dec 31, 2022 | 124.90 Mn |
| Dec 31, 2022 | 124.90 Mn |
| Dec 31, 2021 | 110.50 Mn |
| Dec 31, 2021 | 110.50 Mn |
| Dec 31, 2020 | 86.30 Mn |
| Dec 31, 2020 | 86.30 Mn |
| Dec 31, 2019 | 75.50 Mn |
| Dec 31, 2019 | 75.50 Mn |
| Dec 31, 2018 | 62.14 Mn |
| Dec 31, 2018 | 62.14 Mn |
| Dec 31, 2017 | 38.39 Mn |
| Dec 31, 2017 | 38.39 Mn |
| Dec 31, 2016 | 32.22 Mn |
| Dec 31, 2016 | 32.22 Mn |